Antinociceptive effect of novel trihalomethyl-substituted pyrazoline methyl esters in formalin and hot-plate tests in mice

European Journal of Pharmacology

Volumn 581, Issue 1-2, 2008, Pages 86-96

  Milano, Julie ^a   Oliveira, Sara M ^a   Rossato, Mateus F ^a   Sauzem, Patricia D ^a   Machado, Pablo ^a   Beck, Paulo ^a   Zanatta, Nilo ^a   Martins, Marcos A P ^a   Mello, Carlos F ^b   Rubin, Maribel A ^a   Ferreira, Juliano ^a   Bonacorso, Helio G ^a  

^a Laboratorio de Sintese   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antinociception; Formalin test; Hot plate; Pyrazoline methyl ester derivatives

Indexed keywords

3 METHYL 5 TRICHLOROMETHYL; 3 METHYL 5 TRIFLUOROMETHYL; 4 METHYL 5 TRICHLOROMETHYL; 4 METHYL 5 TRIFLUOROMETHYL; DIPYRONE; FENCLONINE; FORMALDEHYDE; MORPHINE; NALOXONE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; DRUG TOLERANCE; HOT PLATE TEST; INFLAMMATION; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; GASTROINTESTINAL TRANSIT; MALE; MICE; MOTOR ACTIVITY; PAIN MEASUREMENT; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 38549166364     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.042     Document Type: Article

References (45)

1. Beirith A., Santos A.R.S., Rodrigues A.L.S., Creczynski-Pasa T.B., and Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur. J. Pharmacol. 345 (1998) 233-245
2. Bekhit A., and Abdel-Azien T. Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg. Med. Chem. 12 (2004) 1935-1945
3. Camu F., and Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract. Res. Clin. Anaesthesiol. 16 (2002) 475-488
4. Carlsson K.H., Helmreich J., and Jurna I. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone). Pain 27 (1986) 373-390
5. Cheng C.C., Elslager E.F., Werbel L.M., Priebe S.R., and Leopold W.R. Pyrazole derivatives. Synthesis and antineoplastic activity of 3-(2 chloroethyl)-3,4-dihydro-4-oxopyrazolo{5,1-d}-1,2,3,5-tetrazine-8 carboxamide and related compounds. J. Med. Chem. 29 (1986) 1544-1547
6. Collett B.J. Opioid tolerance: the clinical perspective. Br. J. Anaesth. 81 (1998) 58-68
7. Dailly E., Chenu F., Petit-Demoulière B., and Bourin M. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins. J. Neurosci. Methods 150 (2006) 111-115
8. De Souza F.R., Figuera M.R., Lima T.T.F., Bastiani J., Barcellos I.B., Almeida C.E., Oliveira M.R., Bonacorso H.G., Flores A.E., and Mello C.F. 3-Methyl 5-hydroxy-5-trichloromethyl -1H-1-pyrazolcarboxyamide (MPCA) induces antinociception. Pharmacol. Biochem. Behav. 68 (2001) 525-530
9. Edwards J.E., Meseguer F., Faura C.C., Moore R.A., and McQuay H.J. Single-dose dipyrone for acute postoperative pain. Cochrane Database Syst. Rev. 3 (2001) CD003227
10. Ferreira J., Floriani A.E., Filho V.C., Delle Monache F., Yunes R.A., Calixto J.B., and Santos A.R.S. Antinociceptive properties of the methanolic extract and two triterpenes isolated from Epidendrum mosenii stems (Orchidaceae). Life Sci. 66 (2000) 791-802
11. Ferreira J., Campos M.M., Araújo R., Bader M., Pesquero J.B., and Calixto J.B. The use of B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level. Neuropharmacology 43 (2002) 1188-1197
12. 2-Adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazoles, but not of dipyrone. Eur. J. Pharmacol. 496 (2004) 93-97
13. Gürsoy A., Demirayak S., Capan G., Erol K., and Vural K. Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents. Eur. J. Med. Chem. 35 (2000) 359-364
14. Hayes A.G., and Tyers M.B. Determination of receptors that mediate opiate side effects in the mouse. Br. J. Pharmacol. 79 (1983) 731-736
15. Hernández-Delgadillo G.P., Martínez R.V., Reval M.I.D., Ramírez A.M.D., and López-Munoz F.J. Metamizol potentiates morphine antinociception but not constipation after chronic treatment. Eur. J. Pharmacol. 441 (2002) 177-183
16. Hernández-Delgadillo G.P., López-Munoz F.J., Salazar L.A., and Cruz S.L. Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception. Eur. J. Pharmacol. 469 (2003) 71-79
17. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 1 (1987) 103-114
18. Jage J. Opioid tolerance and dependence. Do they matter?. Eur. J. Pain 9 (2005) 157-162
19. Karthikeyan S.M., Holla B.S., and Kumari N.S. Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxyl pyrazolines. Eur. J. Med. Chem. 42 (2007) 30-36
20. Kieffer B.L., and Evans C.J. Opioid tolerance-in search of the holy grail. Cell 108 (2002) 587-590
21. Martins M.A.P., Beck P., Machado P., Brondani S., Moura S., Zanatta N., Bonacorso H.G., and Flores A.F.C. Microwave-assisted synthesis of novel 5-trichloromethyl-4,5-dihydro-1H-1-pyrazole methyl esters under solvent free conditions. J. Braz. Chem. Soc. 17 (2006) 408-411
22. Matheus M.E., Oliveira F.L., and Freitas C.C. Antinociceptive property of new 4-acyl-arylhydrazone pyrazole compounds. Braz. J. Med. Biol. Res. 24 (1991) 1219-1222
23. McQuay H.J., and Moore R.A. NSAIDS and coxibs: clinical use. In: McMahon S., and Koltzenburg M. (Eds). Wall and Melzack's Textbook of Pain (2005), Churchill Livingstone, Edinburgh 471-480
24. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 79 (1999) 1-13
25. Miranda H.F., Lemus I., and Pinardi G. Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Res. Bull. 61 (2003) 417-425
26. 2-adrenoceptors. Eur. J. Pharmacol. 400 (2000) 199-203
27. 3 receptors. Eur. J. Pharmacol. 409 (2000) 167-172
28. Ochi T., Jobo-Magari K., Yonezawa A., Matsumori K., and Fujii T. Anti-inflammatory and analgesics effects of a pyrazole derivative FR140423. Eur. J. Pharmacol. 365 (1999) 259-266
29. Ochi T., Fujii T., Motoyama Y., and Goto T. Antinociceptive properties of FR140423 mediated through spinal δ-, but not μ- and κ-, opioid receptors. Eur. J. Pharmacol. 380 (1999) 73-79
30. Ochi T., Motoyama Y., and Goto T. The spinal antinociceptive effect of FR140423 is mediated through kyotorphin receptors. Life Sci. 66 (2000) 2239-2245
31. Ochi T., Ohkubo Y., and Mutoh S. FR 143166 attenuates spinal pain transmission through activation of the serotonergic system. Eur. J. Pharmacol. 452 (2002) 319-324
32. Otuki M.F., Ferreira J., Lima F.V., Meyre-Silva C., Malheiros A., Muller L.A., Cani G.S., Santos A.R., Yunes R.A., and Calixto J.B. Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways. J. Pharmacol. Exp. Ther. 313 (2005) 310-318
33. Parck K.B., Kitteringham N.R., and O'Neill P.M. Metabolism of fluorine-containing drugs. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 443-470
34. Pasternak G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 22 (2001) 67-70
35. Popova Y., and Staneva-Stoycheva D. Lack of direct interaction of metamyzole with the brain opiate receptors of rats. Acta Physiol. Pharmacol. Bulg. 15 (1989) 55-58
36. Puig M.M., and Pol O. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice. Br. J. Pharmacol. 122 (1997) 1216-1222
37. Santos A.R., Miguel O.G., Yunes R.A., and Calixto J.B. Antinociceptive properties of the new alkaloid, cis-8, 10-di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: evidence for the mechanism of action. J. Pharmacol. Exp. Ther. 289 (1999) 417-426
38. Shibata M., Ohkubo T., Takahashi H., and Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 38 (1989) 347-352
39. Siegfried B., Netto C., and Izquierdo I. Exposure to novetly induces naltrexone-reversible analgesia in rats. Behav. Neurosci. 101 (1987) 436-438
40. Souza F.R., Souza V.T., Ratzlaff V., Borges L.P., Oliveira M.R., Bonacorso H.G., Zanatta N., Martins M.A.P., and Mello C.F. Hypotermic and antipyretic effects of 3-methyl and 3-phenyl-5-hydroxy-5-trichloromethyl-4,5-dihydro-1H-pyrazole-1-carboxyamides. Eur. J. Pharmacol. 451 (2002) 141-147
41. Tabarelli Z., Berlese D.B., Sauzem P.D., Rubin M.A., Missio T.P., Teixeira M.V., Sinhorin A.P., Martins M.A.P., Zanatta N., Bonacorso H.G., and Mello C.F. Antinociceptive effect of novel pyrazolines in mice. Braz. J. Med. Biol. Res. 37 (2004) 1531-1540
42. Tjolsen A., Berge O., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
43. Vlaskovska M., Surcheva S., and Ovcharov R. Importance of endogenous opioids and prostaglandins in the action of analgin (metamizole) and verapamil. Farmakol. Toksikol. 52 (1989) 25-29
44. Whittle B.J.T. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam. Clin. Pharmacol. 17 (2003) 301-313
45. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110